X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Antidepressant Companies (2024 - 2029)

Several prominent companies in the pharmaceutical industry continue to make strides in their respective fields. These firms have been instrumental in developing new treatments and medications, contributing significantly to the advancement of healthcare. Despite facing various challenges, these corporations have demonstrated resilience and innovation, reinforcing their positions as leaders in the pharmaceutical sector. Their ongoing research and development efforts underscore the importance of their work in improving global health outcomes.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Tranquilizers Research Antidepressants Research Antidepressant Market Companies

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Top Companies in Antidepressant Market

This report lists the top Antidepressant companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Antidepressant industry.

  1. GlaxoSmithKline

  2. Sanofi

  3. AstraZeneca

  4. Eli Lilly and Company

  5. Pfizer

*Disclaimer: Top companies sorted in no particular order

Antidepressant Market Major Players

Antidepressant Market Concentration

Antidepressant Market Concentration

Antidepressant Company List

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Cases of Depression Around the World

      2. 4.2.2 Increasing Awareness About Depression

      3. 4.2.3 Emergence of Novel Biologics

    3. 4.3 Market Restraints

      1. 4.3.1 Preference of Non-pharmacological Therapies over Pharmacological Therapies

      2. 4.3.2 Side Effects and Patent Expiry of Antidepressant Drugs

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 Product

      1. 5.1.1 Selective Serotonin Reuptake Inhibitor (SSRI)

      2. 5.1.2 Serotonin-norepinephrine Reuptake Inhibitor (SNRI)

      3. 5.1.3 Tricyclic Antidepressant (TCA)

      4. 5.1.4 Monoamine Oxidase Inhibitor (MAOI)

      5. 5.1.5 Other Products

    2. 5.2 Depressive Disorder

      1. 5.2.1 Major Depressive Disorder

      2. 5.2.2 Obsessive-compulsive Disorder (OCD)

      3. 5.2.3 Generalized Anxiety Disorder (GAD)

      4. 5.2.4 Panic Disorder (PD)

      5. 5.2.5 Other Depressive Disorders

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbiVe Inc.

      2. 6.1.2 AstraZeneca

      3. 6.1.3 Eli Lilly and Company

      4. 6.1.4 GlaxoSmithKline PLC

      5. 6.1.5 Johnson & Johnson

      6. 6.1.6 H. Lundbeck AS

      7. 6.1.7 Merck & Co. Inc.

      8. 6.1.8 Pfizer Inc.

      9. 6.1.9 Sanofi

      10. 6.1.10 Sun Pharmaceuticals Pvt. Ltd

      11. 6.1.11 Dr. Reddy's Laboratories

    2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS


Specific to Antidepressant Market
Need More Details On Market Players And Competitors?
Download PDF

Competitive Landscape Report Includes

Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.

Antidepressant Market Companies Summary

The antidepressant market has seen an increase in growth due to the pandemic, as many individuals have faced mental health challenges due to social isolation, job insecurity, and fear of infection. This has led to an increased demand for effective treatments, with several studies showing the potential therapeutic role of certain antidepressants for COVID-19. These trials have spurred market growth and are expected to continue to do so due to increased awareness about mental health during the pandemic. The market is characterized by a mix of multinational and domestic players, with entry barriers being relatively low and most drugs being available over the counter. Companies in the industry have been actively involved in global expansion through partnerships, collaborations, and acquisitions. This has led to an increase in product portfolios, with a focus on developing and commercializing therapeutics for central nervous system disorders. The approval of new products has created new opportunities, driving segment growth. However, the preference for non-pharmacological therapies over pharmacological ones and the side effects of antidepressant drugs may hinder market growth.

Explore More

Antidepressant Companies - Table of Contents

  1. 1. COMPETITIVE LANDSCAPE

    1. 1.1 Company Profiles

      1. 1.1.1 AbbiVe Inc.

      2. 1.1.2 AstraZeneca

      3. 1.1.3 Eli Lilly and Company

      4. 1.1.4 GlaxoSmithKline PLC

      5. 1.1.5 Johnson & Johnson

      6. 1.1.6 H. Lundbeck AS

      7. 1.1.7 Merck & Co. Inc.

      8. 1.1.8 Pfizer Inc.

      9. 1.1.9 Sanofi

      10. 1.1.10 Sun Pharmaceuticals Pvt. Ltd

      11. 1.1.11 Dr. Reddy's Laboratories

    2. *List Not Exhaustive

Antidepressant Companies FAQs

GlaxoSmithKline PLC, Sanofi, AstraZeneca, Eli Lilly and Company and Pfizer Inc. are the major companies operating in the Antidepressant Market.

Antidepressant Market Report Snapshots

Antidepressant Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)